nodes	percent_of_prediction	percent_of_DWPC	metapath
Azilsartan medoxomil—AGTR1—ACE Inhibitor Pathway—ACE—schizophrenia	0.0445	0.048	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FES—schizophrenia	0.0419	0.0451	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide GPCRs—CCKAR—schizophrenia	0.0184	0.0198	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—DGKI—schizophrenia	0.0183	0.0197	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKI—schizophrenia	0.0163	0.0176	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—NTS—schizophrenia	0.0132	0.0142	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-E—schizophrenia	0.0131	0.0141	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—NTS—schizophrenia	0.013	0.014	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—schizophrenia	0.0118	0.0127	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—blood plasma—schizophrenia	0.0111	0.329	CbGeAlD
Azilsartan medoxomil—Losartan—ACE—schizophrenia	0.0109	0.289	CrCbGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—CHRM1—schizophrenia	0.0108	0.0116	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—ABCB1—schizophrenia	0.0101	0.0109	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—GRM5—schizophrenia	0.01	0.0108	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL10—schizophrenia	0.00984	0.0106	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—TAAR6—schizophrenia	0.00966	0.0104	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM1—schizophrenia	0.00962	0.0104	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—HTR6—schizophrenia	0.00941	0.0101	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—CCK—schizophrenia	0.00915	0.00985	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCK—schizophrenia	0.00903	0.00973	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—schizophrenia	0.00894	0.00963	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—CCKAR—schizophrenia	0.00877	0.00944	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—NTS—schizophrenia	0.00874	0.00941	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCKAR—schizophrenia	0.00866	0.00933	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CHRM1—schizophrenia	0.00832	0.00896	CbGpPWpGaD
Azilsartan medoxomil—Telmisartan—ABCB1—schizophrenia	0.00821	0.218	CrCbGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—schizophrenia	0.00818	0.00881	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR6—schizophrenia	0.00807	0.00869	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—NPY—schizophrenia	0.00784	0.00845	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—schizophrenia	0.00784	0.00845	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—FZD3—schizophrenia	0.00783	0.00843	CbGpPWpGaD
Azilsartan medoxomil—Losartan—CYP1A2—schizophrenia	0.00774	0.205	CrCbGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—OXT—schizophrenia	0.00766	0.00826	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—OXT—schizophrenia	0.00757	0.00815	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—TAAR6—schizophrenia	0.00736	0.00793	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—GRM2—schizophrenia	0.00736	0.00793	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—NPS—schizophrenia	0.00727	0.00783	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—NPS—schizophrenia	0.00717	0.00773	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—HTR2C—schizophrenia	0.00713	0.00767	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CHRM1—schizophrenia	0.00712	0.00767	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—schizophrenia	0.00686	0.00738	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CCKAR—schizophrenia	0.00678	0.0073	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—NTS—schizophrenia	0.00665	0.00717	CbGpPWpGaD
Azilsartan medoxomil—Candesartan—ABCB1—schizophrenia	0.00662	0.175	CrCbGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—ADORA2A—schizophrenia	0.00657	0.00708	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—schizophrenia	0.0065	0.007	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—schizophrenia	0.00637	0.00686	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—GRM3—schizophrenia	0.00626	0.00674	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HTR6—schizophrenia	0.00614	0.00662	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—forebrain—schizophrenia	0.00609	0.18	CbGeAlD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCK—schizophrenia	0.00606	0.00652	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1B—schizophrenia	0.00592	0.00638	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCKAR—schizophrenia	0.00581	0.00626	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1A—schizophrenia	0.0057	0.00614	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—schizophrenia	0.00563	0.00607	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2C—schizophrenia	0.00551	0.00593	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—DRD1—schizophrenia	0.00551	0.00593	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CHRM1—schizophrenia	0.00543	0.00584	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—schizophrenia	0.0054	0.00582	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—DRD3—schizophrenia	0.00533	0.00575	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPY—schizophrenia	0.00526	0.00567	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—DGKI—schizophrenia	0.0052	0.0056	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—DRD4—schizophrenia	0.00518	0.00558	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL1B—schizophrenia	0.00516	0.00556	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—OXT—schizophrenia	0.00508	0.00547	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—schizophrenia	0.00508	0.00547	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—GRM5—schizophrenia	0.00504	0.00543	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CNR1—schizophrenia	0.00494	0.00533	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	0.00489	0.00526	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—DRD2—schizophrenia	0.00482	0.0052	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—HTR7—schizophrenia	0.00482	0.0052	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	0.00481	0.00518	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—DGKI—schizophrenia	0.00472	0.00509	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	0.00472	0.00508	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	0.00472	0.00508	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCK—schizophrenia	0.00461	0.00497	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	0.00457	0.00492	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	0.00444	0.00478	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCKAR—schizophrenia	0.00442	0.00476	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—HTR2A—schizophrenia	0.00437	0.00471	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PPP1R1B—schizophrenia	0.00432	0.00465	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—ADORA2A—schizophrenia	0.00429	0.00462	CbGpPWpGaD
Azilsartan medoxomil—Losartan—ABCB1—schizophrenia	0.00426	0.113	CrCbGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	0.00424	0.00456	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—TAAR6—schizophrenia	0.00416	0.00448	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GRM2—schizophrenia	0.00416	0.00448	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	0.00413	0.00445	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	0.00413	0.00445	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—blood—schizophrenia	0.00407	0.12	CbGeAlD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—schizophrenia	0.00402	0.00433	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—FZD3—schizophrenia	0.00402	0.00433	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—NPY—schizophrenia	0.00401	0.00432	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—schizophrenia	0.00391	0.00421	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HTR1B—schizophrenia	0.00387	0.00416	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—OXT—schizophrenia	0.00387	0.00416	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—NGEF—schizophrenia	0.00385	0.00414	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GRM2—schizophrenia	0.00378	0.00407	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—TAAR6—schizophrenia	0.00378	0.00407	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PPP3CC—schizophrenia	0.00378	0.00407	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—NTS—schizophrenia	0.00376	0.00405	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—TNF—schizophrenia	0.00375	0.00403	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HTR1A—schizophrenia	0.00372	0.00401	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—NPS—schizophrenia	0.00366	0.00395	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HTR2C—schizophrenia	0.00359	0.00387	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—DRD1—schizophrenia	0.00359	0.00387	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—RGS4—schizophrenia	0.00354	0.00381	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GRM3—schizophrenia	0.00354	0.00381	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—endocrine gland—schizophrenia	0.00353	0.104	CbGeAlD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NGEF—schizophrenia	0.00349	0.00376	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—DRD3—schizophrenia	0.00348	0.00375	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HTR6—schizophrenia	0.00347	0.00374	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NTS—schizophrenia	0.00342	0.00368	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	0.00338	0.00364	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—DRD4—schizophrenia	0.00338	0.00364	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—nervous system—schizophrenia	0.00331	0.0977	CbGeAlD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CNR1—schizophrenia	0.00323	0.00347	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—RGS4—schizophrenia	0.00321	0.00346	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GRM3—schizophrenia	0.00321	0.00346	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—central nervous system—schizophrenia	0.00318	0.0941	CbGeAlD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HTR6—schizophrenia	0.00315	0.00339	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HTR7—schizophrenia	0.00315	0.00339	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—DRD2—schizophrenia	0.00315	0.00339	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CHRM1—schizophrenia	0.00307	0.0033	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—IL3RA—schizophrenia	0.00299	0.00322	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.00289	0.00312	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GRM5—schizophrenia	0.00285	0.00307	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—DGKI—schizophrenia	0.00279	0.00301	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CHRM1—schizophrenia	0.00278	0.003	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL3RA—schizophrenia	0.00271	0.00292	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCK—schizophrenia	0.00261	0.00281	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GRM5—schizophrenia	0.00259	0.00279	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PPP1R1B—schizophrenia	0.00255	0.00275	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PDE4B—schizophrenia	0.00254	0.00274	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—brain—schizophrenia	0.00253	0.0747	CbGeAlD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCKAR—schizophrenia	0.0025	0.00269	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—ADORA2A—schizophrenia	0.00242	0.00261	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FZD3—schizophrenia	0.00237	0.00256	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCK—schizophrenia	0.00237	0.00255	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PDE4B—schizophrenia	0.00231	0.00248	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCKAR—schizophrenia	0.00227	0.00244	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—NPY—schizophrenia	0.00226	0.00244	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GRM2—schizophrenia	0.00223	0.0024	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FES—schizophrenia	0.00223	0.0024	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TAAR6—schizophrenia	0.00223	0.0024	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PPP3CC—schizophrenia	0.00223	0.0024	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HTR2A—schizophrenia	0.0022	0.00237	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—ADORA2A—schizophrenia	0.0022	0.00237	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HTR1B—schizophrenia	0.00218	0.00235	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—OXT—schizophrenia	0.00218	0.00235	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HTR1A—schizophrenia	0.0021	0.00226	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—NPS—schizophrenia	0.00207	0.00223	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NGEF—schizophrenia	0.00206	0.00222	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NPY—schizophrenia	0.00206	0.00221	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—DRD1—schizophrenia	0.00203	0.00219	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HTR2C—schizophrenia	0.00203	0.00219	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NTS—schizophrenia	0.00202	0.00217	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HTR1B—schizophrenia	0.00198	0.00214	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—OXT—schizophrenia	0.00198	0.00214	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—DRD3—schizophrenia	0.00197	0.00212	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HTR1A—schizophrenia	0.00191	0.00206	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—DRD4—schizophrenia	0.00191	0.00206	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RGS4—schizophrenia	0.0019	0.00204	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RTN4—schizophrenia	0.0019	0.00204	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GRM3—schizophrenia	0.0019	0.00204	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NPS—schizophrenia	0.00188	0.00203	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HTR6—schizophrenia	0.00186	0.00201	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HTR2C—schizophrenia	0.00184	0.00199	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—DRD1—schizophrenia	0.00184	0.00199	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CNR1—schizophrenia	0.00182	0.00196	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MAG—schizophrenia	0.0018	0.00194	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—DRD3—schizophrenia	0.00179	0.00192	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HTR7—schizophrenia	0.00178	0.00192	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—DRD2—schizophrenia	0.00178	0.00192	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—DRD4—schizophrenia	0.00173	0.00187	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CNR1—schizophrenia	0.00166	0.00178	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CHRM1—schizophrenia	0.00164	0.00177	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—DRD2—schizophrenia	0.00162	0.00174	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HTR7—schizophrenia	0.00162	0.00174	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL3RA—schizophrenia	0.0016	0.00173	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NRG3—schizophrenia	0.00156	0.00168	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TLE1—schizophrenia	0.00156	0.00168	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GFAP—schizophrenia	0.00155	0.00167	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GRM5—schizophrenia	0.00153	0.00165	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TLE3—schizophrenia	0.00148	0.00159	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCK—schizophrenia	0.0014	0.00151	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PDE4B—schizophrenia	0.00136	0.00147	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCKAR—schizophrenia	0.00134	0.00144	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADORA2A—schizophrenia	0.0013	0.0014	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PLA2G4A—schizophrenia	0.00128	0.00138	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FGA—schizophrenia	0.00125	0.00134	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HTR2A—schizophrenia	0.00125	0.00134	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NPY—schizophrenia	0.00121	0.00131	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NOTCH4—schizophrenia	0.00121	0.00131	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ATP2A2—schizophrenia	0.00121	0.00131	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—OXT—schizophrenia	0.00117	0.00126	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HTR1B—schizophrenia	0.00117	0.00126	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HTR2A—schizophrenia	0.00113	0.00122	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HTR1A—schizophrenia	0.00113	0.00121	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NPS—schizophrenia	0.00111	0.0012	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—DRD1—schizophrenia	0.00109	0.00117	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HTR2C—schizophrenia	0.00109	0.00117	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NTRK2—schizophrenia	0.00106	0.00114	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—DRD3—schizophrenia	0.00106	0.00114	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—DRD4—schizophrenia	0.00102	0.0011	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CNR1—schizophrenia	0.000978	0.00105	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—DRD2—schizophrenia	0.000954	0.00103	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HTR7—schizophrenia	0.000954	0.00103	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PRL—schizophrenia	0.000901	0.000971	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—S100B—schizophrenia	0.00084	0.000905	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ERBB4—schizophrenia	0.000803	0.000865	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PLA2G4A—schizophrenia	0.000755	0.000813	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NRG1—schizophrenia	0.000741	0.000798	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MEF2C—schizophrenia	0.000735	0.000791	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—YWHAZ—schizophrenia	0.00071	0.000765	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ERBB3—schizophrenia	0.000694	0.000748	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HTR2A—schizophrenia	0.000668	0.00072	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APOE—schizophrenia	0.000621	0.000669	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APOA1—schizophrenia	0.000614	0.000662	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ESR1—schizophrenia	0.000593	0.000639	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GSK3B—schizophrenia	0.000538	0.00058	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—AKT1—schizophrenia	0.000399	0.00043	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—AKT1—schizophrenia	0.000362	0.00039	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—EP300—schizophrenia	0.000354	0.000381	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TP53—schizophrenia	0.000253	0.000273	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—AKT1—schizophrenia	0.000214	0.00023	CbGpPWpGaD
